Abstract:
Bisphosphonates are drugs used in the treatment of bone diseases, acting by inhibiting bone resorption. Despite their benefits, they are associated with osteonecrosis of the jaws, especially after invasive procedures. This study aimed to review the clinical repercussions of bisphosphonate use in implant dentistry, focusing on the risk of osteonecrosis and surgical management. This is an integrative literature review analyzing 26 sources published between 2016 and 2026. The results indicate that there is no absolute contraindication for implants in patients using oral bisphosphonates, provided that individualized assessment and preventive measures are adopted. Intravenous use, however, presents a higher risk and requires greater caution. It is concluded that treatment success depends on proper planning, conservative protocols, and a multidisciplinary approach.
